emr Archives

TAG:

emr

Machine Learning Poised to Give Clinical Labs New Capabilities

By Robert Michel | From the Volume XXX, Number 16 – November 13, 2023 Issue

“One of the first questions I ask the laboratory team is ‘do you want to continue to be a factory or do you want to be a change agent in healthcare?’ They all answer that they want contribute to positive change.” —Michael Simpson …

Clinisys CEO Discusses Strategic Changes Labs Need to Make

By Robert Michel | From the Volume XXX, Number 15 – October 23, 2023 Issue

“Today, we predict that the next storm is about ready to happen, and it will involve clinical laboratories and anatomic pathology practices.” —Michael Simpson CEO SUMMARY: In this exclusive Q&A with The Dark Report, Clinisys CEO Michael Simpson describes the …

Pharmacogenetic Tests Deliver for Avera Health Lab

By Scott Wallask | From the Volume XXX, No. 6 – April 17, 2023 Issue

CEO SUMMARY: When Avera Institute for Human Genetics wanted to expand its genomics program, it used its past learning with pharmacogenetics to guide the effort. Two key insights? Ask physicians abo…

Laboratories Can Find Value in Use of Leftover Samples

By Scott Wallask | From the Volume XXX, No. 5 – March 27, 2023 Issue

CEO SUMMARY: After testing on behalf of patients, there are often leftover samples. One company developed a platform to enable life science customers to access the samples and associated diagnostic data for research purposes. For clinical labs, the leftover samples provide an opport…

Monitoring Patients on Opioids Is Opportunity for Clinical Labs

By Joseph Burns | From the Volume XXVI No. 13 – September 23, 2019 Issue

CEO SUMMARY: When developing a program to identify and treat patients who misused opioids or needed chronic opioid therapy, Community Health Network (CHN) of Indianapolis recognized that clinical lab toxicology tests were one of the few sources of objective data about patient compliance….

Monitoring Patients on Opioids with Toxicology Screens Is Opportunity for Clinical Labs

By Mary Van Doren | From the Volume XXVI No. 13 – September 23, 2019 Issue

This is an excerpt of a 2,883-word article in the Sept. 23, 2019 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In this first industry briefing on such a program, THE DARK REPORT exp…

Sonic Uses Lab Data, Patient-Contact Tools, to Improve Outcomes

By Joseph Burns | From the Volume XXV No. 16 – November 13, 2018 Issue

CEO SUMMARY: In its work for a federally qualified health center, Sonic Healthcare USA helped physicians use a data-driven approach to population health management that incorporated integrated financial and clinical analytics. Also, Sonic developed technologies that give ordering physicia…

LAB BRIEFS

By Robert Michel | From the Volume XXV No. 4 – March 5, 2018 Issue

DUBAI TO TEST DNA OF ITS 3 MILLION CITIZENS RECENTLY, GOVERNMENT OFFICIALS in Dubai announced a plan to conduct genetic testing on all three million residents. Experts say this is an unprecedented decision by any national govern…

Positive Patient ID System Catches Patients Cheating on Toxicology Tests

By Pamela Scherer McLeod | From the Volume XXIV No. 13 – September 18, 2017 Issue

CEO SUMMARY: The urine drug testing industry is challenged every day to detect the large number of patients trying to cheat on their drug tests. GenoTox Laboratories of Austin, Texas, developed a DNA-authentication method for urine samples that allows the lab to detect when patients have …

UnitedHealth to Start Gene Test Pre-Approval

By Joseph Burns | From the Volume XXIV No. 12 – August 28, 2017 Issue

CEO SUMMARY: With programs now at the nation’s two largest insurers, is it possible to argue that prior-authorization is going mainstream? Some observers say, yes, as THE DARK REPORT predicted. What is certain is that starting Nov. 1, UnitedHealthcare is requiring prior authorization fo…

Volume XXXI, No. 16 – November 25, 2024

Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library

TAG:

emr

CURRENT ISSUE

How Much Laboratory Business Intelligence Have You Missed?

Sign up for TDR Insider

Topics